Autoimmune glial fibrillary acidic protein astrocytopathy mimicking acute ischemic stroke: a case report

Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a recently identified autoimmune disorder of the central nervous system. It commonly manifests as meningitis, encephalitis, myelitis, or optic neuritis. However, presentations resembling stroke are exceedingly rare. Here, we report a case of autoimmune GFAP astrocytopathy initially misdiagnosed as acute ischemic stroke. The correct diagnosis was later established through the detection of GFAP antibodies in both the patient's serum and cerebrospinal fluid (CSF) using a cell-based assay (CBA). The patient initially responded to corticosteroid therapy; however, a relapse occurred during the tapering phase. After one year of treatment with oral prednisone and azathioprine, the patient achieved remission, with a subsequent negative result for GFAP antibodies. At the three-year follow-up, no recurrence was observed.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-04-22
DOI
https://doi.org/10.3389/fimmu.2026.1768290
Primary Topic
Autoimmune Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Autoimmune glial fibrillary acidic protein astrocytopathy mimicking acute ischemic stroke: a case report

Ting Chen, Kaibin Qin, Xu Hou, Xun Mo et al.
Frontiers in Immunology
Autoimmune Neurological Disorders and Treatments
article

Autoimmune glial fibrillary acidic protein astrocytopathy mimicking acute ischemic stroke: a case report

Ting Chen, Kaibin Qin, Xu Hou, Xun Mo, S F Yu
article en

Abstract

Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a recently identified autoimmune disorder of the central nervous system. It commonly manifests as meningitis, encephalitis, myelitis, or optic neuritis. However, presentations resembling stroke are exceedingly rare. Here, we report a case of autoimmune GFAP astrocytopathy initially misdiagnosed as acute ischemic stroke. The correct diagnosis was later established through the detection of GFAP antibodies in both the patient's serum and cerebrospinal fluid (CSF) using a cell-based assay (CBA). The patient initially responded to corticosteroid therapy; however, a relapse occurred during the tapering phase. After one year of treatment with oral prednisone and azathioprine, the patient achieved remission, with a subsequent negative result for GFAP antibodies. At the three-year follow-up, no recurrence was observed.

Frontiers in ImmunologyVol. 17
Affiliated Hospital of Guizhou Medical University (CN), Guiyang University (CN), Nanyang Medical College (CN)
Good health and well-being
Openalex Percentile: Top 20%
Autoimmune Neurological Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Autoimmune glial fibrillary acidic protein astrocytopathy mimicking acute ischemic stroke: a case report — Ting Chen, Kaibin Qin, et al. · Frontiers in Immunology (2026) | TGRS Research Map | TGRS